期刊文献+

丹参酮Ⅱ_A在大鼠肝微粒体酶中的代谢动力学 被引量:14

Metabolic kinetics of tanshinone Ⅱ_A in rat liver microsomal enzyme
下载PDF
导出
摘要 目的研究丹参酮ⅡA在大鼠肝微粒体酶中的代谢,以及选择性细胞色素P450(CYP)酶抑制剂对其代谢的影响。方法超速离心法制备大鼠肝微粒体,采用高效液相-质谱联用方法测定孵育液中丹参酮ⅡA原形药物的浓度。研究丹参酮ⅡA的酶促动力学,推导出药物米氏常数(Km)和最大反应速度(Vmax);并计算体外酶对药物的清除率(CLint)。同时观察不同浓度和不同种类的CYP酶特异性抑制剂对丹参酮ⅡA代谢的影响。结果丹参酮ⅡA在大鼠肝微粒体酶中的Vmax为(1.20±0.18)nmol/(min·mg);Km为(4.35±0.67)nmol/mL;CLint为(0.28±0.06)mL/(min·mg)。噻氯匹啶和酮康唑能够显著抑制丹参酮ⅡA的代谢,奎尼丁对丹参酮ⅡA的代谢也有一定的抑制作用,而其他CYP酶抑制剂对丹参酮ⅡA的代谢无明显影响。结论CYP2C19和CYP3A1主要参与了丹参酮ⅡA的代谢,CYP2D6也起到了部分代谢作用;这些CYP酶的抑制剂可能使丹参酮ⅡA的代谢受到抑制,造成药物药效或毒性的增加。 Objective To study the metabolic kinetics of tanshinone ⅡA and the effects of selective CYP450 inhibitors on the metabolism of tanshinone Ⅱ A in rat liver microsomal enzyme. Methods Rat liver microsomes were prepared by using uhracentrifugation method. Tanshinone ,Ⅱ A concentration in the incubation pool was determined by LC/LC/MS method. The Michaelis-Menten parameters Km and Vmax in rat liver microsomes were initially estimated by analyzing Lineweave-Brurk plot. The clearance (CLint) was calculated for in vitro enzyme to tanshinone Ⅱ A. Various selective CYP inhibitors were used to investigate their inhibitory effects on the metabolism of tanshinone Ⅱ A and the principal CYP isoforms involved in tanshinone ⅡA metabolic ring. Results The Vmax, Km, and Cint, of tanshinone Ⅱ A were (1. 20±0. 18) nmol/(min · mg), (4. 35±0. 67) nmol/mL, and (0. 28±0. 06) mL/(min · mg), respectively. The metabolism of tanshinone Ⅱ A was significantly inhibited by ticlopidine and ketoconazole. Quinidine could inhibit the metabolism of tanshinone Ⅱ A, while the other inhibitors showed little inhibitory effect on the metabolism of tanshinone ⅡA. Conclusion It is shown that CYP2C19 and CYP3A1 are involved in the metabolism of tanshinone Ⅱ A and CYP2D6 contribute to the metabolism to some extent. Their selective CYP inhibitors may have potential inhibition on metabolism of tanshinone Ⅱ A and make the efficacy or toxicity increased.
出处 《中草药》 CAS CSCD 北大核心 2007年第6期882-886,共5页 Chinese Traditional and Herbal Drugs
基金 广州新药临床前评价研究技术平台(广州市重大项目 2004Z1-E4051)
关键词 丹参酮ⅡA 代谢 肝微粒体 细胞色素P450(CYP) tanshinone ⅡA metabolism liver microsomes CYP
  • 相关文献

参考文献6

  • 1WuH HeZB WuHB.Review on tanshinones'''' pharmacological actions .现代中西医结合杂志,2005,14(10):1832-1885.
  • 2石乃玉,董华民,黄海金.丹参酮药理及临床应用[J].中国医师杂志,2001,3(2):150-151. 被引量:139
  • 3梁勇,羊裔明,袁淑兰.丹参酮药理作用及临床应用研究进展[J].中草药,2000,31(4):304-306. 被引量:264
  • 4Lowry O H, Rosebrough N J, Farr A L, et al. Protein measurement with the Folin phenol reagent[J]. J Biol Chem, 1951, 193:265-275.
  • 5Bjornsson T D, Callaghan J T, Einolf H J, et al. The conduct of in vitro and in vivo drug-drug interaction studies : a pharmaceutical research and manufactures of America (PhRMA) perspective[J]. Drug Metab Dispos, 2003, 31: 518-832.
  • 6Donato M T, Castell J V. Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism[J].Clin Pharmacokinet, 2003, 42: 153-178.

二级参考文献24

共引文献389

同被引文献235

引证文献14

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部